This week's Guest Voice is Richard Bayliss, who talks about three coping tools he's found useful in living with sickle cell ...

Osaic chief market strategist Phil Blancato joins 'Making Money' to discuss the impact of consumer behavior on the stock ...

C-reactive protein levels significantly higher during follicular vs luteal phase, which may contribute to pattern of painful vaso-occlusive events. HealthDay News — For adults with sickle cell ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

For those battling sickle cell disease, pain and fear are tragically routine, yet a significant scientific advancement offers newfound optimism for the UK's 17,500 affected individuals.

Repetitive transcranial magnetic stimulation (rTMS ... publication year, sample size, age, disease duration, and stimulation site 2) Baseline characteristics, intervention details, and pre-and ...

Period-driven inflammation could influence the risk of pain events among women with sickle cell disease Levels of C-reactive protein increase among women with sickle cell disease during the first ...

While both sickle cell trait and sickle cell disease involve mutations in the haemoglobin gene, they are fundamentally different in terms of symptoms, severity, and impact on daily life.

wiping out teams working on research about adults with cognitive disabilities and sickle cell disease. Work likely to be halted by the cuts includes the collection of data for studying Americans ...

Scientists at Raman Research Institute (RRI) have developed an affordable electro-fluidic device that aids in preliminary screening of Sickle Cell Disease (SCD). According to RRI, the innovative ...

NHS patients with sickle cell disease can now benefit from a groundbreaking gene-editing treatment that holds the potential to cure the condition. The one-off gene therapy, exagamglogene autotemcel ...

Get Instant Summarized Text (Gist) Research has identified the protein QRICH1 as a potential target for modulating T-cell activation in cancer and autoimmune diseases. QRICH1 acts as a partial ...